Zurcher Kantonalbank (Zurich Cantonalbank) - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 89 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$8,267
-91.2%
1,694
-74.0%
0.00%
-100.0%
Q3 2022$94,000
-5.1%
6,5130.0%0.00%0.0%
Q2 2022$99,000
+350.0%
6,513
+248.7%
0.00%
Q1 2022$22,000
-26.7%
1,8680.0%0.00%
Q4 2021$30,000
-43.4%
1,8680.0%0.00%
Q3 2021$53,000
-42.4%
1,8680.0%0.00%
-100.0%
Q4 2020$92,000
+27.8%
1,8680.0%0.00%0.0%
Q3 2020$72,000
+148.3%
1,868
+178.4%
0.00%
Q2 2020$29,0006710.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$932,9393.08%
Sofinnova Investments, Inc. 2,194,278$10,708,0770.64%
Artal Group S.A. 400,000$1,9520.11%
Polar Capital Holdings Plc 1,991,929$9,720,6140.08%
ASHFORD CAPITAL MANAGEMENT INC 98,870$482,4860.08%
Soleus Capital Management, L.P. 87,182$425,4480.06%
GSA CAPITAL PARTNERS LLP 99,160$4840.06%
Cormorant Asset Management, LP 150,000$7320.05%
CORNERCAP INVESTMENT COUNSEL INC 48,233$235,3770.04%
XTX Topco Ltd 38,574$188,2410.04%
View complete list of Y-MABS THERAPEUTICS INC shareholders